Initiation of fluticasone propionate–salmeterol after a COPD-related hospitalization or ED visit decreased the risk of a recurrent event and reduced COPD-related medical costs. Objectives: To quantify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results